Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 416,355 $ 377,581
Accounts receivable, net 10,069 6,605
Inventories 17,653 13,642
Prepaid expenses and other current assets 4,611 3,089
Contract assets 3,018 1,466
Total current assets 451,706 402,383
Property, plant and equipment, net 159,983 106,795
Patents, net 1,819 1,801
Right-of-use assets 16,546 19,387
Leverage loans receivable 13,408 13,408
Restricted cash 524 2,316
Loan fees 1,548 0
Other assets 71 111
Total assets 645,605 546,201
Current liabilities    
Accounts payable 18,970 10,610
Accrued liabilities 5,901 9,220
Unearned revenue and contract liabilities 822 2,455
Current portion of lease liability 2,947 3,000
Current portion of long-term debt, net 333 25,201
Total current liabilities 28,973 50,486
Private warrants liability 59,302 82,860
Long-term lease liability, net 20,581 24,175
Long-term debt, net 29,576 31,386
Other long-term liabilities 625 1,250
Total liabilities 139,057 190,157
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.0001 par value; 200,000,000 shares authorized: 97,732,079 and 84,535,640 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 9 8
Additional paid-in capital 620,808 414,819
Accumulated deficit (114,269) (58,783)
Total stockholders’ equity 506,548 356,044
Total liabilities and stockholders’ equity $ 645,605 $ 546,201